Table of Contents

Editorials

• You have access

  Reciprocal activation of antigen-presenting cells and CAR T cells triggers a widespread endogenous anti-tumor immune response through sustained high-level IFNγ production

  Yelei Guo, Chuan Tong, Zhiqiang Wu, Yuting Lu, Yao Wang and Weidong Han

  Cancer Biology & Medicine November 2023, 20 (11) 779-782; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0324
• You have access

  Emerging trends in clinical cancer genomic research

  Yingyan Yu

  Cancer Biology & Medicine November 2023, 20 (11) 783-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0383
• You have access

  Using triple radio-immunotherapy to overcome cancer immunotherapy resistance

  Zengfu Zhang, Xiaodong Zhang and Dawei Chen

  Cancer Biology & Medicine November 2023, 20 (11) 788-794; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0268
• You have access

  Bacterial therapy: a promising strategy for cancer immunotherapy

  Yinsong Wang

  Cancer Biology & Medicine November 2023, 20 (11) 795-798; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0292
• You have access

  Single-arm trials for domestic oncology drug approvals in China

  Hong Zhang, Sen Liu, Chenghao Ge, Xiaozhen Liu, Yang Liu, Chen Yin, Yi Li, Jing An, Zhongtian Yan and Xiaoyuan Chen

  Cancer Biology & Medicine November 2023, 20 (11) 799-805; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0360